Read + Share
Zucenka A, Griskevicius L. Gilteritinib in combination with venetoclax, low-dose cytarabine and actinomycin
D for relapsed or refractory FLT3-mutated acute myeloid leukaemia. Br J Haematol 2024;204:1227-1231.
PMID: 38291741
|
 |
|
Zucenka A, Griskevicius L. Gilteritinib in combination with venetoclax, low-dose cytarabine and actinomycin
D for relapsed or refractory FLT3-mutated acute myeloid leukaemia. Br J Haematol 2024;204:1227-1231.
PMID: 38291741
|
|
|
|